Higher isoform of hnRNPA1 confer Temozolomide resistance in U87MG & LN229 glioma cells.

MLA

Bhardwaj, Sachin, et al. “Higher Isoform of HnRNPA1 Confer Temozolomide Resistance in U87MG & LN229 Glioma Cells.” Journal of Neuro-Oncology, vol. 171, no. 1, Jan. 2025, pp. 47–63. EBSCOhost, https://doi.org/10.1007/s11060-024-04831-y.

APA

Bhardwaj, S., Sanjay, & Yadav, A. K. (2025). Higher isoform of hnRNPA1 confer Temozolomide resistance in U87MG & LN229 glioma cells. Journal of Neuro-Oncology, 171(1), 47–63. https://doi.org/10.1007/s11060-024-04831-y

Chicago

Bhardwaj, Sachin, Sanjay, and Ajay Kumar Yadav. 2025. “Higher Isoform of HnRNPA1 Confer Temozolomide Resistance in U87MG & LN229 Glioma Cells.” Journal of Neuro-Oncology 171 (1): 47–63. doi:10.1007/s11060-024-04831-y.